Korea Information Service

Il Sung Pharm. (003120)

STOCK


	(Unit : %, Times)

Fiscal Year End	2004.12.31	2005.12.31	2006.12.31	2007.12.31	2008. 3.31
Net Income to Total Assets	11.20	16.15	16.00	4.61	5.24
Ordinary Income to Total Assets	16.72	22.73	22.54	6.81	7.18
Operating Profit to Working Capital	14.20	17.25	22.84	26.85	26.85
Net Income to Equity	12.55	18.63	18.98	5.62	6.55
Net Income to Sales	20.04	36.49	49.03	22.45	30.83
Ordinary Income to Sales	29.92	51.36	69.08	33.13	42.28
Operating Income to Sales	22.86	25.83	26.86	25.94	26.28
Total Income to Sales	45.61	49.45	52.66	53.03	48.69
Times Interest earned	18,979.92	12,653.35	1,478.55	786.34	84.81
Financial Expenses/Sales	-	-	0.05	0.04	0.50
Equity to Total Assets	90.12	84.36	84.22	80.96	78.97
Liability to Equity	10.96	18.54	18.73	23.51	26.62
Borrowings & Bonds to Assets	-	-	-	-	2.15
Current Liabilities to Equity	10.31	13.36	9.65	2.82	6.59
Fixed Assets to Equity & L/T Liabilities	19.45	70.04	80.63	92.42	91.11
Fixed Ratio	19.58	73.66	87.95	111.54	109.37
Current Ratio	886.53	335.82	318.85	424.49	261.98
Quick Ratio	789.14	282.26	253.54	284.07	202.68
Debt Coverage Ratio	1,447,294.50	958,383.40	109,718.63	57,883.08	273.84
Total C/F to Liabilities	124.72	48.96	29.36	17.58	-
Business Capital Turn over	0.62	0.67	0.85	1.04	1.03
Total Assets Turn over	0.56	0.44	0.33	0.21	0.17
Trade Receivables Turn over	3.37	3.47	3.24	3.08	3.11
Inventories Turn over	5.15	6.10	5.80	5.19	5.40
Trade Payables Turn over	13.54	15.68	14.23	19.60	24.14
Sales Growth	4.77	7.97	1.82	0.32	7.92
Total Asset Growth	21.87	48.12	31.34	80.70	0.79
Equity Growth	24.67	38.66	31.13	73.71	- 1.68


	(Unit : %)


	(Unit : 100Mn. Won, %)